Autopsy report · NCT03796650

Fecal Transplantation for Primary Clostridium Difficile Infection

“Pre-specified non-inferiority criterion met at interim analysis.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 4 years 9 months before it stopped.
• 104 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Oslo University Hospital

Sponsor type

University, hospital or other

Conditions

Clostridium Difficile Infection

Interventions

Fecal microbiota transplantation; Vancomycin

Participants

104

Sites

18

Countries

Norway

Trials that died the same way

• A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility
  “Lack of efficacy determined at interim analysis” (63% match in meaning)
• The Mepilex Cesarean Delivery Trial
  “Proposed superiority study framework was not approved by the IRB. Study will be redeveloped as a non-inferiority study and resubmitted to the IRB.” (60% match in meaning)
• ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients
  “Lack of effect in interim analysis” (59% match in meaning)
• A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
  “Interim assessment: Lack of efficacy” (58% match in meaning)
• Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer
  “Interim analysis determined the study did not meet criteria to proceed” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.